Carlos Alfredo Almazan Hernandez
Research Subjects
Carlos Alfredo Almazan Hernandez has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Blanco Silva
Instituto Mexicano del Seguro Social, Critical Medicine Department, Ciudad de México-México
1 shared publication - Claudio Sandoval
Universidad Cientifica del Sur, Rheumatology, Lima Peru
1 shared publication - Felipe Eduardo Macías Prado
Hospital Alfredo Paulson
1 shared publication - Jesús Miguel Figueroa Zaldívar
Internal Medicine Residency Program, Centro de Investigación y Docencia en Ciencias de la Salud, Universidad Autónoma de Sinaloa, Hospital Civil de Culiacán, Culiacán, Mexico
1 shared publication - Melanie Mishel Ponce Saldaña
Universidad de San Martín de Porres, Medical Department, Lima, Perú
1 shared publication - Melina Carlos Tovar
Instituto mexicano del seguro social, Internal Medicine. Torreón, México
1 shared publication
Latest Publications
- Open Access
- 2 September 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 2087
Impact of mechanical circulatory support modalities on outcomes in acute myocardial infarction-related cardiogenic shock undergoing early revascularization: A systematic review of survival and cardiac function outcomes
Introduction: Cardiogenic shock complicates 5–10% of acute myocardial infarctions and remains associated with early mortality of approximately 40%. Mechanical circulatory support devices, including intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation, are increasingly applied, yet their effect on outcomes is uncertain. Objectives: This review aimed to systematically evaluate the impact of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation on survival and left ventricular function in patients with acute myocardial infarction complicated by cardiogenic shock undergoing early revascularization. Methods: A systematic search of PubMed, ScienceDirect, and the Cochrane Library was conducted up to May 1, 2025. Eligible studies included randomized controlled trials and observational studies assessing intra-aortic balloon pump, Impella, or extracorporeal membrane oxygenation in acute myocardial infarction–related cardiogenic shock. Two reviewers independently screened studies, extracted data, and assessed quality using Cochrane RoB 2.0 and ROBINS-I tools. Sixteen studies encompassing more than 35,000 patients were included. Results: Across all modalities, mechanical circulatory support did not consistently improve short- or long-term survival. Randomized trials showed no benefit for intra-aortic balloon pump in survival or ventricular recovery. Impella use was associated with higher rates of bleeding and vascular complications without mortality advantage. Extracorporeal membrane oxygenation demonstrated the highest complication rates. Early Impella deployment showed limited potential for ventricular recovery in select cases, but results were inconsistent. Conclusions: Despite theoretical hemodynamic benefits, current evidence does not demonstrate consistent improvements in survival or left ventricular function with intra-aortic balloon pump, Impella, or extracorporeal membrane oxygenation in acute myocardial infarction complicated by cardiogenic shock. High complication rates, particularly with Impella and extracorporeal membrane oxygenation, offset potential benefits, underscoring the need for timely revascularization rather than reliance on mechanical circulatory support.
- 2 September 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 2087
Open AccessImpact of mechanical circulatory support modalities on outcomes in acute myocardial infarction-related cardiogenic shock undergoing early revascularization: A systematic review of survival and cardiac function outcomes
Introduction: Cardiogenic shock complicates 5–10% of acute myocardial infarctions and remains associated with early mortality of approximately 40%. Mechanical circulatory support devices, including intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation, are increasingly applied, yet their effect on outcomes is uncertain. Objectives: This review aimed to systematically evaluate the impact of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation on survival and left ventricular function in patients with acute myocardial infarction complicated by cardiogenic shock undergoing early revascularization. Methods: A systematic search of PubMed, ScienceDirect, and the Cochrane Library was conducted up to May 1, 2025. Eligible studies included randomized controlled trials and observational studies assessing intra-aortic balloon pump, Impella, or extracorporeal membrane oxygenation in acute myocardial infarction–related cardiogenic shock. Two reviewers independently screened studies, extracted data, and assessed quality using Cochrane RoB 2.0 and ROBINS-I tools. Sixteen studies encompassing more than 35,000 patients were included. Results: Across all modalities, mechanical circulatory support did not consistently improve short- or long-term survival. Randomized trials showed no benefit for intra-aortic balloon pump in survival or ventricular recovery. Impella use was associated with higher rates of bleeding and vascular complications without mortality advantage. Extracorporeal membrane oxygenation demonstrated the highest complication rates. Early Impella deployment showed limited potential for ventricular recovery in select cases, but results were inconsistent. Conclusions: Despite theoretical hemodynamic benefits, current evidence does not demonstrate consistent improvements in survival or left ventricular function with intra-aortic balloon pump, Impella, or extracorporeal membrane oxygenation in acute myocardial infarction complicated by cardiogenic shock. High complication rates, particularly with Impella and extracorporeal membrane oxygenation, offset potential benefits, underscoring the need for timely revascularization rather than reliance on mechanical circulatory support.